0001209191-16-147902.txt : 20161102 0001209191-16-147902.hdr.sgml : 20161102 20161102161546 ACCESSION NUMBER: 0001209191-16-147902 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20161031 FILED AS OF DATE: 20161102 DATE AS OF CHANGE: 20161102 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CELGENE CORP /DE/ CENTRAL INDEX KEY: 0000816284 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 222711928 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 86 MORRIS AVENUE CITY: SUMMIT STATE: NJ ZIP: 07901 BUSINESS PHONE: (908)673-9000 MAIL ADDRESS: STREET 1: 86 MORRIS AVENUE CITY: SUMMIT STATE: NJ ZIP: 07901 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PEHL MICHAEL F. CENTRAL INDEX KEY: 0001677939 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34912 FILM NUMBER: 161968005 MAIL ADDRESS: STREET 1: C/O CELGENE CORPORATION STREET 2: 86 MORRIS AVENUE CITY: SUMMIT STATE: NJ ZIP: 07901 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2016-10-31 0 0000816284 CELGENE CORP /DE/ CELG 0001677939 PEHL MICHAEL F. C/O CELGENE CORPORATION 86 MORRIS AVENUE SUMMIT NJ 07901 0 1 0 0 See remarks Stock Option (right to buy) 102.18 2016-10-31 4 A 0 21392 0.00 A 2026-10-31 Common Stock 21392 21392 D Restricted Stock Unit 2016-10-31 4 A 0 7308 0.00 A Common Stock 7308 7308 D Option is immediately exercisable and will vest in four equal annual installments commencing on October 31, 2017. The option was issued pursuant to the Company's 2008 Stock Incentive Plan (as Amended and Restated as of April 15, 2015). Each restricted stock unit represents a contingent right to receive one share of the Company's common stock. The restricted stock units were issued pursuant to the Company's 2008 Stock Incentive Plan (Amended and Restated as of April 15, 2015) and will vest on October 31, 2019. Vested shares will be delivered to the reporting person on the vesting date. President, Hematology & Oncology /s/ Mark J. Alles_____________________________ Mark J. Alles, Attorney-in-Fact 2016-11-02